The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Official Title: Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
Study ID: NCT00716209
Brief Summary: The proposal seeks to establish: * A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records. * A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators. * A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members. * To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
National University Hospital, Singapore, , Singapore
Name: Ross Andrew Soo, MBBS
Affiliation: National University Hospital, Singapore
Role: PRINCIPAL_INVESTIGATOR
Name: Alex Chang
Affiliation: Johns Hopkins Singapore International Medical Centre
Role: PRINCIPAL_INVESTIGATOR
Name: Chung Yip Chan
Affiliation: Tan Tock Seng Hospital
Role: PRINCIPAL_INVESTIGATOR